A Message from CancerCare Manitoba

CancerCare Manitoba is the provincially mandated cancer agency and we provide clinical services to both children and adults. Read the latest message from our President and CEO.

News

November is Radon Awareness Month

November 24, 2023 11:16 AM

November is Radon Awareness Month. This month, take a closer look at the hidden threat in your home: radon. ... read more...

CCMB Board Annual Public Forum

November 17, 2023 11:30 AM

Please join us for the CancerCare Manitoba Board Annual Public Forum on Friday, December 1, 2023 from 12:30-1:30 p.m. ... read more...

Upcoming Patient Webinar: Preventing Broken Hearts in Patients with Cancer

November 16, 2023 3:54 PM

Join us on Wednesday, December 6, from 12-1:00 p.m. for a patient webinar on Preventing Broken Hearts in Patients with Cancer. View the poster. ... read more...

News Release: CancerCare Manitoba Launches New Indigenous Community Profiles Website

November 9, 2023 1:30 PM

November 9, 2023 Website Launched to Enhance Health Care Professionals' Understanding of Indigenous Community Resources CancerCare Manitoba (CCMB), in collaboration with First Nation, Métis, and ... read more...


Supporting Patients and their Families.
The Navigator Newsletter

CancerCare Manitoba provides a variety of support groups and services to assist patients and their families through their cancer journey. Take a look at our monthly newsletter for details.


Research & Education.

The goal of the Research Institute at CancerCare Manitoba is to have a positive impact on the lives of cancer patients. The Research Institute at CCMB, in partnership with the University of Manitoba was unveiled in 2015 with an expanded mandate covering all aspects of cancer and blood disorder research.


Where You Can Find Us.

CancerCare Manitoba offers services in a variety of locations all across the province of Manitoba.Take a look at our locations page for detailed information on specific sites.


CancerCare Manitoba Foundation

All funds donated to CancerCare Manitoba Foundation remain in Manitoba. These funds support CancerCare Manitoba's internationally recognized team of health professionals who provide outstanding care for patients and their families.

The Foundation’s mission, in partnership with donors, is to support CancerCare Manitoba’s strategic priorities. This year is the Foundation’s 20th anniversary, a significant milestone marking two decades of investment and progress.

Thanks to the generosity of many donors, CancerCare Manitoba Foundation has been able to grant more than $151 million since 2000. This support to CancerCare Manitoba profoundly impacts patient outcomes.

Donors have made a Canadian first possible

Donor generosity is enabling Manitoba to be a national leader. Thanks to your incredible investment, prostate cancer patients have access to leading-edge radiation treatments here at home. Your steadfast commitment is helping cure men living with this disease. Men like John Unger.

We encourage you to to watch how your donations have impacted John.

Your support of local research saves lives

Cancer has been a part of Peggy Miller’s life for nearly thirteen years. She is living proof the research you contribute to at CancerCare Manitoba changes lives for the better. Your generosity makes research and trials possible in our province.

We encourage you to to watch how you're supporting research at CancerCare Manitoba.


Shine A Light

Shine a Light in memory, in honour or in gratitude of that special person in your life. Their light will shine throughout December helping and inspiring Manitobans affected by cancer.

Visit ShineMB.ca to get your light.

Join us for the Lighting Ceremony on December 1st at 5:00 pm, east side of the CancerCare Manitoba building at 675 McDermot Ave.

Giving Tuesday

This GivingTuesday you can help create change for Manitobans with cancer.

Join the movement to support local cancer research and be a hero in someone’s story.

DONATE HERE.

iA Financial Group is generously matching all donations up to $25,000.

LEARN MORE.